CSNK1A1 and cancer: Mutations and dysregulated expression and/or activity of CK1 isoforms can promote the development of pathological conditions such as cancer (Tsai et al., 2007; Umar et al., 2007; Brockschmidt et al., 2008; Knippschild et al., 2014; Janovská et al., 2020), neurodegenerative diseases (Okochi et al., 2000; Kametani et al., 2009), and inflammatory processes (Marin et al., 2002; Wang et al., 2014).